Internal Medicine / Oncology

The Washington University physicians in the Department of Internal Medicine encompass 14 specialty clinical divisions.

Over 270 physicians in the department of medicine treat patients with a wide range of diseases, disorders and conditions.

Text Size: S M L

Home > Physicians Directory > Internal Medicine / Oncology

Ravi Vij, MD

Specialty Areas
Oncology
Myelodysplastic Syndrome
Hematologic Malignancies
Bone Marrow Transplant
Multiple Myeloma
Leukemia

Areas of Clinical Interest
Stem cell transplant, multiple myeloma, myelodysplastic syndrome, hematologic malignancy, leukemia

Areas of Research Interest
Transplant, multiple myeloma, myelodysplastic syndrome, hematologic malignancy, leukemia

Major or Recent Publications/Awards

Honors and Awards

Listed in Best Doctors in America, 2005-2009 (Best Doctors, Inc)

Teacher of the year (Hematology/Oncology Fellowship Program) 2007

Amgen Hematology Oncology Fellowship Award, 1999

AACR/ASCO Scholarship: Methods in Clinical Cancer Research, Third Annual Workshop, 1998

Reviewer

Blood
Bone Marrow Transplantation
Journal of Clinical Oncology
Haematologica

Books and Book Chapters

Vij R. Optimizing the dasatinib dose regimen in chronic phase chronic myeloid leukemia (CP CML): 100 mg once daily available for use. (Manuscript accepted Community Oncology)

Vij R. In Defense of High Dose Chemotherapy for Multiple Myeloma. American Journal of Hematology and Oncology April 2007 Vol 6 (3) Supple 3 (17-19)

Wildes T, Vij R. Multiple Myeloma and Plasma Cell Dyscrasias. Washington Manual of Oncology. 2nd edition (In press)

Vij R. Plasma Cell Neoplasms. Cancer: Principles and Practices of Oncology Review, First Edition. (Lippincott Williams and Wilkins, 2005)

Vij R. Recent advances in stem cell transplantation. Medicine Update (Anniversary Issue 2003)

Vij R, DiPersio. Cytokines in Allogeneic Stem Cell Mobilization. Allogeneic Stem Cell Transplantation Clinical Research and Practice, Humana Press 2003:159-168


Selected Journal Articles

Uy G, Goyal SN, Fisher N, Oza A, Tomasson M, Stockerl-Goldstein K, DiPersio JF and Vij R. Phase II study of bortezomib pre and post transplant for multiple myeloma. (Manuscript accepted Bone Marrow Transplantation)

Iskra Pusic, Shi Yuan Jiang, Scott Landua, Geoffrey L. Uy, Michael P. Rettig, Amanda F. Cashen, Peter Westervelt, Ravi Vij, Camille N. Abboud, Keith E. Stockerl-Goldstein, Diane S. Sempek, Angela L. Smith, John F. DiPersio. Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation. Biology of Blood and Marrow Transplantation Volume 14, Issue 9, Pages 949-1080

Devine SM, Vij R et al. Rapid mobilization of functional donor hematopoietic cells without G-CSF using plerixafor, an antagonist of the CXCR4/SDF-1 interaction (Blood 2008; 112:990-998)

Drew J. Winston, Jo-Anne H. Young, Vinod Pullarkat, Genovefa Papanicoloau, Ravi Vij, Estil Vance, George J. Alangaden, Roy F. Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Stephen A. Villano, and Michael Boeckh. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem-cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study (Blood June 2008, 111(11): 5403-10)

Tanya M. Wildes, Kristan M. Augustin, Diane Sempek, Qin Jean Zhang, Ravi Vij, John Dipersio1, Steven M Devine. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed Non-Hodgkin Lymphoma. (Biology of Blood and Marrow Transplantation, 2008, 14(7): 840-846)

Uy GF, Trivedi R, Peles S, Fisher M, Zhang J, Tomasson M, DiPersio JF, Vij R. In-vivo Effects of Bortezomib on Lymphocyte Subsets and Markers of Bone Turnover. (Clinical Lymphoma and Myeloma, Dec 2007)

Fong T, Trinkaus K, Adkins D, Vij R, Devine S, Tomasson M, Goodnough LT, Lopez S Graubert T, Shenoy S, DiPersio JF, Khoury H. A randomized double blind trial of hydroxychloroqine for the prevention of chronic graft versus host disease after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2007 Oct;13(10):1201-6

Fong F, Vij R, Vijayan A , DiPersio JF, Blinder M. Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome. (Haematologica. 2007 92 (10): 1431-2)

Uy GL, Tomasson MH, Ruddell A, DiPersio JF, Vij R. The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma. Haematologica. 2006 Nov;91(11):1581-2

Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Devine S, Vij R, Lin HS, DiPersio J, Adkins D. Long-term remissions in patients with high risk myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cgy total body irradiation and cyclophosphamide. Biol Blood Marrow Transplant. 2006 Jul;12(7):749-57

Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, Augustin K, Vij R, Trinkaus K, DiPersio J, Adkins D. Prophylactic granulocyte transfusions given following allogeneic peripheral blood stem cell transplantation result in a modest reduction of febrile days and intraveneous antibiotic usage. Transfusion. 2006 Jan;46(1):14-23

Verkruyse LA, Storch GA, Devine SM, DiPersio JF, Vij R. Once Daily Ganciclovir As Initial Pre-emptive Therapy Delayed Until Threshold CMV Load >10000 copies/ml: a Safe and Effective Strategy For Allogeneic Stem Cell Transplant Patients Bone Marrow Transplant. 2006 Jan;37(1):51-6

Brenner W, Storch G, Buller R, Vij R, Devine S, DiPersio J. West Nile Virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance (BMT; 2005 (36), 369-70)

Devine S, Brown R, Matthews V, Trinkaus K, Khoury H, Adkins D, Vij R, Sempek D, Graubert T, Tomasson M, Goodnough L, DiPersio J. Effects of alternative cytokine regimens for mobilization of peripheral blood cells from HLA-identical sibling donors: evidence that mobilization with GM-CSF alone may reduce the risk of acute GVHD compared with G-CSF. (BMT 2005; 36, 531-538)

Freidman J, Khoury K, Adkins D, Devine S, Nervi B, Edwards T, DiPersio J, Vij R. 13 cis-Retinoic Acid+ Dexamethasone+ Alpha Interferon: An Active Combination When Used as Maintenance Therapy following High Dose Chemotherapy and Autologous Bone Marrow Transplant in Patients With Multiple Myeloma. (BMT 2005 ; 35, 979-984)

Girgis M, Hallemeier C, Blum W, Brown R, Lin H, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Oza A, DiPersio J, Adkins D. Chimerism and clinical outcomes of 110 unrelated donor bone marrow transplant recipients conditioned with low dose (550cGy), single exposure total body irradiation and cycleophosphamide. Blood 2005; 105 (8) 3035-4


For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Vij